Fushine Pharma: Key Clients for VC and FEC Products Include Tinci Materials and Capchem

Deep News11-14

Jiangxi Fushine Pharmaceutical Co., Ltd. announced on November 14 that during a Q&A session with investors, the company disclosed its current annual production capacity of 8,000 tons for VC products and approximately 4,000 tons for FEC products.

Plans are underway to expand VC production capacity to 10,000 tons per year through technical upgrades, with completion expected by Q2 2026. Further capacity expansions for both VC and FEC products—to 20,000 tons and 5,000 tons annually, respectively—will be implemented based on market demand and industry capacity developments.

The company's primary clients for VC and FEC products include Guangzhou Tinci Materials Technology Co., Ltd. and Shenzhen Capchem Technology Co., Ltd.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1169368448?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-14 20:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1169368448","market":"sh","top_or_hot":-1,"title":"Fushine Pharma: Key Clients for VC and FEC Products Include Tinci Materials and Capchem","media":"Deep News","content":"<p>Jiangxi Fushine Pharmaceutical Co., Ltd. announced on November 14 that during a Q&A session with investors, the company disclosed its current annual production capacity of 8,000 tons for VC products and approximately 4,000 tons for FEC products.</p>\n<p>Plans are underway to expand VC production capacity to 10,000 tons per year through technical upgrades, with completion expected by Q2 2026. Further capacity expansions for both VC and FEC products—to 20,000 tons and 5,000 tons annually, respectively—will be implemented based on market demand and industry capacity developments.</p>\n<p>The company's primary clients for VC and FEC products include Guangzhou Tinci Materials Technology Co., Ltd. and Shenzhen Capchem Technology Co., Ltd.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fushine Pharma: Key Clients for VC and FEC Products Include Tinci Materials and Capchem</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFushine Pharma: Key Clients for VC and FEC Products Include Tinci Materials and Capchem\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time\">2025-11-14 20:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Jiangxi Fushine Pharmaceutical Co., Ltd. announced on November 14 that during a Q&A session with investors, the company disclosed its current annual production capacity of 8,000 tons for VC products and approximately 4,000 tons for FEC products.</p>\n<p>Plans are underway to expand VC production capacity to 10,000 tons per year through technical upgrades, with completion expected by Q2 2026. Further capacity expansions for both VC and FEC products—to 20,000 tons and 5,000 tons annually, respectively—will be implemented based on market demand and industry capacity developments.</p>\n<p>The company's primary clients for VC and FEC products include Guangzhou Tinci Materials Technology Co., Ltd. and Shenzhen Capchem Technology Co., Ltd.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0543330566.HKD","symbol_name":"TEMPLETON BRIC \"A\" (HKD) ACC","start_time":0,"source_url":"","article_id":"1169368448","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1169368448","pubTimestamp":1763124042,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"Jiangxi Fushine Pharmaceutical Co., Ltd. announced on November 14 that during a Q&A session with investors, the company disclosed its current annual production capacity of 8,000 tons for VC products...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"300037":"新宙邦","300497":"富祥药业","LU0543330566.HKD":"TEMPLETON BRIC \"A\" (HKD) ACC","BK4124":"机动车零配件与设备","LU0029874905.USD":"TEMPLETON EMERGING MARKETS \"A\" INC","VC":"伟世通","BK0077":"质押式回购","002709":"天赐材料","BK0239":"医药制造","BK0076":"特斯拉","IE00BZ199S13.USD":"BNY MELLON MOBILITY INNOVATION \"B\" (USD) ACC","LU0320764243.SGD":"FTIF - Templeton Emerging Markets A Acc SGD","BK0155":"锂电池","BK0003":"超级电容","BK0028":"国家队","IE0005HP3H50.USD":"GUINNESS CHINA \"C\" (USD) ACC","BK0201":"可转债","BK0132":"高送转概念","LU0128522744.USD":"TEMPLETON EMERGING MARKETS \"A\" ACC","LU0757428866.USD":"THREADNEEDLE (LUX) GLOBAL SMALLER COMPANIES \"AE\" (USD) ACC","LU1815336091.USD":"THREADNEEDLE (LUX) GLOBAL SMALLER COMPANIES \"AUP\" (USD) INC","LU0229945570.USD":"TEMPLETON BRIC \"A\" (USD) ACC","LU0708995153.HKD":"TEMPLETON EMERGING MARKETS \"A\" (HKD) ACC","BK0229":"化学制品"},"translate_title":"富欣药业：VC和FEC产品的主要客户包括天赐材料和Capchem","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300037":1,"300497":1,"VC":1,"002709":1},"content_text":"Jiangxi Fushine Pharmaceutical Co., Ltd. announced on November 14 that during a Q&A session with investors, the company disclosed its current annual production capacity of 8,000 tons for VC products and approximately 4,000 tons for FEC products.\nPlans are underway to expand VC production capacity to 10,000 tons per year through technical upgrades, with completion expected by Q2 2026. Further capacity expansions for both VC and FEC products—to 20,000 tons and 5,000 tons annually, respectively—will be implemented based on market demand and industry capacity developments.\nThe company's primary clients for VC and FEC products include Guangzhou Tinci Materials Technology Co., Ltd. and Shenzhen Capchem Technology Co., Ltd.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1169368448","isCrawlerRequest":true}